Campath® and Rituxan® Promising for Untreated High-risk CLL
October 7, 2008 — Researchers from the Mayo Clinic have reported that early treatment of asymptomatic patients with high-risk features of chronic lymphocytic leukemia (CLL) with Campath® (alemtuzumab) and Rituxan® (rituximab) appears promising. The details of this study appeared in the October 15, 2008 issue of Cancer.
Long-term Incense Use Increases Risk of Cancer Upper Respiratory Tract Cancer
October 7, 2008 — Researchers from Singapore have reported that long-term incense use increases the risk of squamous cell carcinoma of the respiratory tract. The details of this study appeared in the October 1, 2008 issue of Cancer.
Vitamin D deficiency makes bowel disease worse
October 7, 2008 — NEW YORK (Reuters Health) - A vitamin D deficiency can make inflammatory bowel disease more severe and worsen the quality of life for affected individuals, according to a study presented this week at the 73rd annual scientific meeting of the American College of Gastroenterology.
Select news items provided by Reuters Health